JSB Market Research: Myasthenia Gravis - Pipeline Review, H2 2014
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. See Full Report @ http://bit.ly/1BXnzhj
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
See Full Report @ http://bit.ly/1BXnzhj
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Number of Products by Stage and Molecule Type, <strong>H2</strong> <strong>2014</strong> 40<br />
<strong>Myasthenia</strong> <strong>Gravis</strong> Therapeutics - Recent <strong>Pipeline</strong> Updates, <strong>H2</strong> <strong>2014</strong> 64<br />
<strong>Myasthenia</strong> <strong>Gravis</strong> - Dormant Projects, <strong>H2</strong> <strong>2014</strong> 79<br />
<strong>Myasthenia</strong> <strong>Gravis</strong> - Discontinued Products, <strong>H2</strong> <strong>2014</strong> 80<br />
List Of Figures<br />
Number of Products under Development for <strong>Myasthenia</strong> <strong>Gravis</strong>, <strong>H2</strong> <strong>2014</strong> 9<br />
Number of Products under Development for <strong>Myasthenia</strong> <strong>Gravis</strong> - Comparative Analysis, <strong>H2</strong><br />
<strong>2014</strong> 10<br />
Number of Products under Development by Companies, <strong>H2</strong> <strong>2014</strong> 11<br />
Comparative Analysis by Clinical Stage Development, <strong>H2</strong> <strong>2014</strong> 15<br />
Comparative Analysis by Early Stage Products, <strong>H2</strong> <strong>2014</strong> 16<br />
Assessment by Monotherapy Products, <strong>H2</strong> <strong>2014</strong> 32<br />
Number of Products by Top 10 Targets, <strong>H2</strong> <strong>2014</strong> 33<br />
Number of Products by Stage and Top 10 Targets, <strong>H2</strong> <strong>2014</strong> 34<br />
Number of Products by Top 10 Mechanism of Actions, <strong>H2</strong> <strong>2014</strong> 35<br />
Number of Products by Stage and Top 10 Mechanism of Actions, <strong>H2</strong> <strong>2014</strong> 36<br />
Number of Products by Top 10 Routes of Administration, <strong>H2</strong> <strong>2014</strong> 37<br />
Number of Products by Stage and Top 10 Routes of Administration, <strong>H2</strong> <strong>2014</strong> 38<br />
Number of Products by Top 10 Molecule Types, <strong>H2</strong> <strong>2014</strong> 39<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language